We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$605M
Cap. Flow %
41.62%
Top 10 Hldgs %
67.23%
Holding
768
New
377
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
1
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$265M 18.22%
3,040,000
+1,740,000
+134% +$151M
QQQ icon
2
Invesco QQQ Trust
QQQ
$450B
$247M 16.96%
787,250
+13,644
+2% +$4.36M
LQD icon
3
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$107M 7.38%
825,000
IWM icon
4
iShares Russell 2000 ETF
IWM
$80.2B
$92M 6.32%
416,430
+6,430
+2% +$1.4M
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$76M 5.22%
191,700
-3,233
-2% -$1.25M
XBI icon
6
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$54.6M 3.75%
402,494
+322,494
+403% +$48.3M
SMFG icon
7
Sumitomo Mitsui Financial
SMFG
$164B
$46M 3.16%
6,341,605
-60,000
-0.9% -$418K
XLV icon
8
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$39.7M 2.73%
340,000
CTLP
9
DELISTED
Cantaloupe
CTLP
$26.6M 1.83%
2,272,778
+50,000
+2% +$527K
ESTA icon
10
Establishment Labs
ESTA
$2.75B
$24.1M 1.66%
386,047
+69,246
+22% +$3.99M
AVDL
11
DELISTED
Avadel Pharmaceuticals
AVDL
$22.6M 1.55%
2,495,573
+603,530
+32% +$4.88M
ITOS
12
DELISTED
iTeos Therapeutics
ITOS
$20.1M 1.38%
+588,238
New +$21.3M
UPST icon
13
Upstart Holdings
UPST
$2.59B
$12.9M 0.89%
+100,400
New +$7.7M
QNGY
14
DELISTED
Quanergy Systems, Inc.
QNGY
$10.7M 0.74%
+53,525
New +$11.5M
FULC icon
15
Fulcrum Therapeutics
FULC
$248M
$10.4M 0.71%
+881,832
New +$10.9M
ML
16
DELISTED
MoneyLion Inc.
ML
$10.3M 0.71%
34,377
SST icon
17
System1
SST
$14.5M
$9.96M 0.68%
100,000
BWAY
18
Brainsway
BWAY
$612M
$8.84M 0.61%
1,957,518
+1,111,558
+131% +$4.81M
TALK icon
19
Talkspace
TALK
$873M
$8.84M 0.61%
890,804
+790,804
+791% +$8.59M
BLNK icon
20
Blink Charging
BLNK
$70.4M
$8.23M 0.57%
+200,300
New +$8.73M
XGN icon
21
Exagen
XGN
$113M
$7.91M 0.54%
451,821
+135,271
+43% +$2.41M
CP icon
22
Canadian Pacific Kansas City
CP
$78.3B
$7.7M 0.53%
+101,550
New +$7.31M
COLIU
23
DELISTED
Colicity Inc. Units
COLIU
$7.62M 0.52%
+754,527
New +$7.7M
LGACU
24
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$7.5M 0.52%
+750,000
New +$7.63M
APPH
25
DELISTED
AppHarvest, Inc. Common Stock
APPH
$7.17M 0.49%
+391,943
New +$10.1M

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $605M of net new capital in Q1 2021, opening 377 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 377 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.